All Stories

  1. Enterobacter adelaidei sp. nov. Isolation of an extensively drug resistant strain from hospital wastewater in Australia and the global distribution of the species
  2. Identification of potential high-risk clones of Carbapenem-ResistantPseudomonas aeuroginosaco-producing, KPC-2, VIM-2 and OXA-74 from tertiary hospitals in Metro Manila, Philippines
  3. New antibiotics to combat One Health AMR
  4. Multidrug‐resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat
  5. Resistome Analysis of Klebsiella pneumoniae Complex from Residential Aged Care Facilities Demonstrates Intra-facility Clonal Spread of Multidrug-Resistant Isolates
  6. Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics
  7. Identification and evolution of ICE-PmuST394: a novel integrative conjugative element in Pasteurella multocida ST394
  8. Recommendations of Key Elements within an Integrated Monitoring Framework of Antimicrobial Resistance for Asian Countries
  9. The scope of antimicrobial resistance in residential aged care facilities determined through analysis of Escherichia coli and the total wastewater resistome
  10. Orthogonal Reversed-Phase C18 and Pentafluorophenyl HPLC Separation for Phytochemical Profiling of Serrulatanes in Eremophila denticulata
  11. Combined Structure- and Ligand-Based Approach for the Identification of Inhibitors of AcrAB-TolC in Escherichia coli
  12. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-i...
  13. Genomic profiling of Pasteurella multocida isolated from feedlot cases of bovine respiratory disease
  14. Adding to the family of resistance factors against last resort antibiotics: Identification and characterization of a novel carbapenemase, CIM-1
  15. Design and synthesis of benzochromene derivatives as AcrB inhibitors for the reversal of bacterial multidrug resistance
  16. Polypharmacology-Labeled Molecular Networking: An Analytical Technology Workflow for Accelerated Identification of Multiple Bioactive Constituents in Complex Extracts
  17. Targeting malaria parasites with novel derivatives of azithromycin
  18. In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
  19. Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division
  20. Antimicrobial susceptibility and genomic analysis of Histophilus somni isolated from cases of bovine respiratory disease in Australian feedlot cattle
  21. Lacritin Bactericidal Peptide N‐104 Targeting of Inner Membrane Transporters FeoB and PotH (SpuG) Individually Absent in N‐104 Resistant Strains of Human Opportunistic Pathogen, P. aeruginosa PA14
  22. Correction: Alhamami et al. First Emergence of Resistance to Macrolides and Tetracycline Identified in Mannheimia haemolytica and Pasteurella multocida Isolates from Beef Feedlots in Australia. Microorganisms 2021, 9, 1322
  23. The Structural and Functional Study of Efflux Pumps Belonging to the RND Transporters Family from Gram-Negative Bacteria
  24. Complete Genome Sequence of Pasteurella multocida Sequence Type 394, Isolated from a Case of Bovine Respiratory Disease in Australia
  25. Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model
  26. Worldwide distribution and environmental origin of the Adelaide imipenemase (AIM-1), a potent carbapenemase in Pseudomonas aeruginosa
  27. Bioactivity-guided isolation of compounds from Sophora flavescens with antibacterial activity against Acinetobacter baumannii
  28. An optimized and robust PEG precipitation method for detection of SARS-CoV-2 in wastewater
  29. Taking AIM-(1) at carbapenem resistance in Pseudomonas aeruginosa
  30. Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci
  31. SdiA, a Quorum-Sensing Regulator, Suppresses Fimbriae Expression, Biofilm Formation, and Quorum-Sensing Signaling Molecules Production in Klebsiella pneumoniae
  32. First Emergence of Resistance to Macrolides and Tetracycline Identified in Mannheimia haemolytica and Pasteurella multocida Isolates from Beef Feedlots in Australia
  33. Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections
  34. Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis
  35. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
  36. Comparison of Two Transmission Electron Microscopy Methods to Visualize Drug-Induced Alterations of Gram-Negative Bacterial Morphology
  37. Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance
  38. A pH-neutral electrolyzed oxidizing water significantly reduces microbial contamination of fresh spinach leaves
  39. Neutral electrolyzed oxidizing water is effective for pre-harvest decontamination of fresh produce
  40. Catecholic alkaloid sulfonates and aromatic nitro compounds from Portulaca oleracea and screening of their anti-inflammatory and anti-microbial activities
  41. Antimicrobial Action and Reversal of Resistance in MRSA by Difluorobenzamide Derivatives Targeted at FtsZ
  42. Design and synthesis of aryl-substituted pyrrolidone derivatives as quorum sensing inhibitors
  43. Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance
  44. Efflux Pump-Driven Antibiotic and Biocide Cross-Resistance in Pseudomonas aeruginosa Isolated from Different Ecological Niches: A Case Study in the Development of Multidrug Resistance in Environmental Hotspots
  45. In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice
  46. Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors
  47. Comparative antibacterial activities of neutral electrolyzed oxidizing water and other chlorine-based sanitizers
  48. Disinfection options for irrigation water: Reducing the risk of fresh produce contamination with human pathogens
  49. Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance
  50. Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro
  51. Antimicrobial effects of cinnamon essential oil and cinnamaldehyde combined with EDTA against canine otitis externa pathogens
  52. In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens
  53. Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens
  54. Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance
  55. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators
  56. Induction of Escherichia coli into a VBNC state through chlorination/chloramination and differences in characteristics of the bacterium between states
  57. Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing
  58. Genomic characterization of coagulase-negative staphylococci including methicillin-resistant Staphylococcus sciuri causing bovine mastitis
  59. Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine
  60. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance
  61. Substitution of terminal amide with 1 H -1,2,3-triazole: Identification of unexpected class of potent antibacterial agents
  62. Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors
  63. Efficacy evaluation of a new water sanitizer for increasing the shelf life of Southern Australian King George Whiting and Tasmanian Atlantic Salmon fillets
  64. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
  65. Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors
  66. Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines
  67. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
  68. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition
  69. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance
  70. Synthesis and antibacterial activity of novel 3- O -descladinosylazithromycin derivatives
  71. Bio-augmentation and nutrient amendment decrease concentration of mercury in contaminated soil
  72. Structural model of FeoB, the iron transporter from Pseudomonas aeruginosa, predicts a cysteine lined, GTP-gated pore
  73. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
  74. Synthesis and Biological Evaluation of Novel FtsZ‐targeted 3‐arylalkoxy‐2,6‐difluorobenzamides as Potential Antimicrobial Agents
  75. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
  76. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump
  77. Expression, purification and functional reconstitution of FeoB, the ferrous iron transporter from Pseudomonas aeruginosa
  78. Structure of the AcrAB–TolC multidrug efflux pump
  79. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets
  80. Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa
  81. A Multidrug ABC Transporter with a Taste for Salt
  82. Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions
  83. On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA
  84. Two Proton Translocation Pathways in a Secondary Active Multidrug Transporter
  85. New light on multidrug binding by an ATP-binding-cassette transporter
  86. Similarities between ATP-dependent and ion-coupled multidrug transporters
  87. Drug-Lipid A Interactions on the Escherichia coli ABC Transporter MsbA
  88. A critical role of a carboxylate in proton conduction by the ATP‐binding cassette multidrug transporter LmrA
  89. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2)
  90. Reversible Transport by the ATP-binding Cassette Multidrug Export Pump LmrA
  91. Purification and properties of theEscherichia colinucleoside transporter NupG, a paradigm for a major facilitator transporter sub-family
  92. An ABC transporter with a secondary-active multidrug translocator domain
  93. A new dimer interface for an ABC transporter
  94. The ATP Binding Cassette Multidrug Transporter LmrA and Lipid Transporter MsbA Have Overlapping Substrate Specificities
  95. Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactis
  96. Molecular dissection of membrane-transport proteins: mass spectrometry and sequence determination of the galactose‒H+ symport protein, GalP, of Escherichia coli and quantitative assay of the incorporation of [ring-2-13C]histidine and 15NH3
  97. Do mammals make their own morphine?
  98. Expression of prokaryotic membrane transport proteins in Escherichia coli
  99. Purification and Characterization of a Metalloprotease fromChryseobacterium indologenesIx9a and Determination of the Amino Acid Specificity with Electrospray Mass Spectrometry
  100. Equipping a Research Scale Fermentation Laboratory for Production of Membrane Proteins